[1]
Ufuk İLGEN and Orhan KÜÇÜKŞAHİN 2020. Additional Benefit of Canakinumab on Proteinuria in a Case With Muckle-Wells Syndrome in Remission Under Anakinra. Archives of Rheumatology. 35, 1 (Mar. 2020), 149–150. DOI:https://doi.org/10.5606/ArchRheumatol.2020.7378.